Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • WDC vs GSK✓SelectedUSD · GSKWDC vs GSK performance historyLatest closeAs of-12.02%11/20
Stock and ETF performance explorer

WDC vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+86.5%
GSK return
+6.1%
Excess return
+80.4%
Maximum drawdown
-65.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-12.0%-0.1%-11.9%-12.1%
7D-11.7%-5.3%-6.4%-13.5%
30D-31.0%-3.7%-27.4%-31.7%
3M-44.3%-7.3%-37.1%-45.1%
6M-43.2%-4.2%-38.9%-43.9%
YTD+51.7%+0.9%+50.9%+49.8%
1Y+86.5%+7.3%+79.3%+86.3%
All+86.5%+6.1%+80.4%+86.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling